YUNGPO SU, MD
Hematology & Oncology Physician · OMAHA, NE
Individual Active NPI 1457322166
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 609 | 204,436 | $9,531,816 | $4,113,038 | $3,269,149 |
| 2023 | 599 | 150,454 | $7,810,442 | $3,342,849 | $2,656,750 |
| 2022 | 590 | 146,180 | $5,341,426 | $2,198,099 | $1,747,153 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 42,160 | $31 | $25 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 21,369 | $27 | $22 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 20,250 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 19,204 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 17,250 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 6,989 | $0 | $0 |
| J1434 | Injection, fosaprepitant (focinvez), 1 mg | 6,450 | $3 | $2 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 2,772 | $26 | $20 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,568 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,620 | $1 | $1 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 948 | $4 | $3 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 920 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 23746 | NE |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Nebraska
- NPI 1891347886
- NPI 1568556314
- NPI 1124076997
- NPI 1932189396
- NPI 1639120975
- NPI 1073686812
- NPI 1366513517
- NPI 1629061528
See all Hematology & Oncology Physician providers in Nebraska →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.